CD4+ T cell-mediated antigen-specific immunotherapy in a mouse model of cervical cancer.
about
Immature myeloid cells directly contribute to skin tumor development by recruiting IL-17-producing CD4+ T cellsLymphocytes in cancer development: polarization towards pro-tumor immunityB cells regulate macrophage phenotype and response to chemotherapy in squamous carcinomas.Alarmin IL-33 acts as an immunoadjuvant to enhance antigen-specific tumor immunityCombined immunostimulation and conditional cytotoxic gene therapy provide long-term survival in a large glioma model.TGFβ in T cell biology and tumor immunity: Angel or devil?Relationship between the inflammatory molecular profile of breast carcinomas and distant metastasis development.Impact of CD68/(CD3+CD20) ratio at the invasive front of primary tumors on distant metastasis development in breast cancerFcRgamma activation regulates inflammation-associated squamous carcinogenesis.Infiltrating neutrophils mediate the initial angiogenic switch in a mouse model of multistage carcinogenesis.CD4(+) T cells regulate pulmonary metastasis of mammary carcinomas by enhancing protumor properties of macrophages.CSF1R inhibition delays cervical and mammary tumor growth in murine models by attenuating the turnover of tumor-associated macrophages and enhancing infiltration by CD8(+) T cellsPrognostic value of neutrophil distribution in cholangiocarcinoma.Induction of antitumor immunity in vivo following delivery of a novel HPV-16 DNA vaccine encoding an E6/E7 fusion antigen.The prognostic value of tumor-infiltrating neutrophils in gastric adenocarcinoma after resection.Induction of CD4-independent E7-specific CD8+ memory response by heat shock fusion proteinEffects of the tumor microenvironment on the efficacy of tumor immunotherapy.Overexpression of matrix metalloproteinases and their inhibitors in mononuclear inflammatory cells in breast cancer correlates with metastasis-relapse.Human papillomavirus vaccine: progress and the future.Reengineering dendritic cell-based anti-cancer vaccines.Tumor-infiltrating regulatory T cells inhibit endogenous cytotoxic T cell responses to lung adenocarcinoma.HPV variants and HLA polymorphisms: the role of variability on the risk of cervical cancer.Interactions between lymphocytes and myeloid cells regulate pro- versus anti-tumor immunityThe biology of personalized cancer medicine: facing individual complexities underlying hallmark capabilities.Inflammation and cancer.Depletion of CD4 T cells enhances immunotherapy for neuroblastoma after syngeneic HSCT but compromises development of antitumor immune memory.Enhanced activation of human dendritic cells by silencing SOCS1 and activating TLRs simultaneously.Deletion of RBP-J in dendritic cells compromises TLR-mediated DC activation accompanied by abnormal cytoskeleton reorganization.Diet-induced obesity may affect the uterine immune environment in early-mid pregnancy, reducing NK-cell activity and potentially compromising uterine vascularization.
P2860
Q28256749-14C08AC9-CE4B-4717-89B1-0C423E80F681Q33712435-4B506D3D-F7D1-4484-BAEB-462DDA381ECBQ33776937-D3526B33-F002-43C2-816A-C7E87CBE651DQ34033407-F91DFA9F-FA03-4A1E-BD42-A44636D86F60Q34063140-A741C35E-EC6B-4172-97B7-FAF9D39B0962Q34276027-28D6AEC1-ACF0-41C5-AA1D-9BEBB6928130Q34473935-4BB21962-5263-47A3-8DBA-1620C4372931Q34541239-7F1670D3-DEA5-4114-86D7-C998B55978AFQ34859537-70F74303-35B2-4025-B13F-FD1289E58BD2Q34928194-955545EA-A29F-46C5-8B5B-369BA0BB6130Q34995099-911C92C5-BA20-43F5-8817-35E013BBD90FQ35086934-17DF3829-6310-4A44-8D3C-CE31021706EFQ35534078-B295C85F-D106-4360-B851-E3D675A2EFC4Q35771332-6A6604F4-7C58-4703-A7E6-3D9510A189AEQ35839920-FBD59B76-D885-4A14-A3F9-499121DAFCADQ36097148-EA12C551-60B9-4356-A8E9-25E7F547BBC4Q36569004-CA45CA6A-1114-4D71-B1CA-BDC58DE07976Q36611308-98A4C6D3-D5A2-4866-A1FD-2E8C72DC1D91Q36764915-F3541F0B-AB73-4A81-B808-B773D94496C5Q37118177-52A93594-106C-4CC1-9AE8-85CE7367DE91Q37175625-D5E9C47C-CCFD-451C-BB97-BD1EEEC6BDCFQ37448947-8CD9CBFC-D727-4442-85C0-30A9D64BAA54Q37734258-25766664-250F-4237-B609-9C44B31F4527Q37987661-65F268B5-6B40-4CE3-A786-1EA8E26861D9Q41853728-1E224F75-DC10-41E3-9355-3941189DA56CQ43129396-585FC0BD-5525-4987-8C4E-8D3C59D84AF7Q43510234-01D77ECF-4F0E-422D-8621-522EEC8E265BQ43678721-EFBAB8B7-BF83-4C84-A6AC-886AF62C8081Q50718728-17A9C57B-64E2-4E20-92EE-CB26408C631A
P2860
CD4+ T cell-mediated antigen-specific immunotherapy in a mouse model of cervical cancer.
description
2005 nî lūn-bûn
@nan
2005 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի մարտին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
CD4+ T cell-mediated antigen-specific immunotherapy in a mouse model of cervical cancer.
@ast
CD4+ T cell-mediated antigen-specific immunotherapy in a mouse model of cervical cancer.
@en
type
label
CD4+ T cell-mediated antigen-specific immunotherapy in a mouse model of cervical cancer.
@ast
CD4+ T cell-mediated antigen-specific immunotherapy in a mouse model of cervical cancer.
@en
prefLabel
CD4+ T cell-mediated antigen-specific immunotherapy in a mouse model of cervical cancer.
@ast
CD4+ T cell-mediated antigen-specific immunotherapy in a mouse model of cervical cancer.
@en
P2093
P1433
P1476
CD4+ T cell-mediated antigen-specific immunotherapy in a mouse model of cervical cancer.
@en
P2093
Christopher Chiu
Douglas Hanahan
Dylan Daniel
Enrico Giraudo
Lee A Mizzen
Masahiro Inoue
N Randall Chu
P304
P356
10.1158/0008-5472.CAN-04-3444
P407
P577
2005-03-01T00:00:00Z